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The widespread use of cone-beam CT (CBCT) in dentistry has led to increasing concern regarding justification and optimisation
of CBCT exposures. When used as a substitute to multidetector CT (MDCT), CBCT can lead to significant dose reduction;
however, low-dose protocols of current-generation MDCTs show that there is an overlap between CBCT and MDCT doses.
More importantly, although the 3D information provided by CBCT can often lead to improved diagnosis and treatment com-
pared with 2D radiographs, a routine or excessive use of CBCTwould lead to a substantial increase of the collective patient dose.
The potential use of CBCT for paediatric patients (e.g. developmental disorders, trauma and orthodontic treatment planning)
further increases concern regarding its proper application. This paper provides an overview of justification and optimisation
issues in dental and maxillofacial CBCT. The radiation dose in CBCT will be briefly reviewed. The European Commission’s
Evidence Based Guidelines prepared by the SEDENTEXCT Project Consortium will be summarised, and (in)appropriate use of
CBCTwill be illustrated for various dental applications.
CONE-BEAM CT: A PARADIGM SHIFT
IN DENTAL IMAGING
Cone-beam CT (CBCT) was introduced into dental
imaging more than 15 y ago. It has proved to be a
useful modality for imaging of the hard tissues and
air cavities of the dental and ear–nose–throat areas.
The introduction of CBCT has dramatically altered
the perception on the use of three-dimensional (3D)
imaging for dental applications. Whereas the use of
CT imaging was limited in dentistry before, CBCT
has now become an integral part of the diagnostic
toolset for several dental specialties. It is currently
applied for several purposes, such as implant plan-
ning, endodontics, orthodontics and maxillofacial
surgery(1). About 50 CBCT models are currently on
the market, exhibiting a wide range in selectable ex-
posure parameters [kVp, mAs, field of view (FOV)
size, etc.].
The widespread use of CBCT can be attributed to
several factors. A crucial advantage of CBCT, albeit
not related to radiological protection, is accessibility.
The low cost, small size and limited medico-legal
requirements of CBCT allow it to be placed in dental
practices and clinics that cannot accommodate a mul-
tidetector CT (MDCT). Several benefits are asso-
ciated with this, such as reduced treatment time and
increased patient comfort.
Other advantages relate to the imaging perform-
ance of CBCT compared with two-dimensional (2D)
imaging modalities (e.g. intra-oral and panoramic
radiography) and MDCT. The ability to acquire a
three-dimensional image can result in superior diag-
nostic capabilities and a more accurate treatment
planning compared with 2D radiographs. Compared
with MDCT, the increased sharpness of CBCT allows
for the visualisation of small structures in the dental
area (e.g. root lesions). Both of these considerations
justify the use of CBCT for a subset of dental patients
but proper nuance is needed. The added value of 3D
imaging, at least when used routinely, is considered
questionable for certain dental applications and lacks
conclusive evidence(1). Regarding image sharpness
compared with MDCT, it has been shown that a wide
range in image quality exists in CBCT, with some
CBCTs demonstrating a lower resolution than that of
MDCT(2).
In addition, several misconceptions about CBCT
imaging are commonly seen. It is often described as a
‘low-dose’ modality, which is falsely attributed to the
fact that it requires only a single rotation (or less)
around the scanned object. In fact, similar to the
range in image quality, a wide range in doses is seen
in CBCT, overlapping with doses from MDCT and
panoramic radiography(3 – 8). Also, it is typically
deemed ‘fast’, although the scan time of a CBCT sig-
nificantly exceeds that of current-generation MDCTs
and, in many cases, that of a panoramic radiograph.
While it is indisputable that CBCT has a rightful
place in dental imaging and has the ability to improve
patient treatment in many cases, it is important to
temper the overall optimism and to keep stressing the
importance of radiological protection issues associated
with the use of this modality. The following section will
go deeper into the topic of radiation dose in CBCT. A
summary of the European Commission’s Evidence
Based Guidelines prepared by the SEDENTEXCT
Project Consortium will be given(1). Next, a few exam-
ples of proper and improper use of CBCT will be
demonstrated with the aid of various guidelines and
position statements, and future prospects for CBCT
imaging will be discussed.
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RADIATION DOSE IN CBCT
Patient dose for dental CBCT has been extensively
reported(3 – 7). The variety of dosimetric information
available, involving different CBCT models, dose
metrics and methodologies, complicates a compari-
son between studies and inhibits the drawing of
general conclusions. However, a few general consid-
erations can be made regarding doses and risks from
CBCT, and how these relate to those from alternative
imaging modalities.
An obvious, yet important, finding is that CBCT
shows a wide dose range, as can be expected from the
variable exposure parameters used by different
models. Small FOVs can be used to scan the area of a
single tooth, whereas certain large FOVs cover most
of the patient’s head. Clinical kVp values range
between 70 and 120 kV, whereas mAs values range
more than 20-fold but are generally between 25 and
150 mAs.
Measuring effective doses for clinical dental proto-
cols of 14 CBCT models, Pauwels et al. showed a
19-fold dose range(4), whereas Ludlow et al. measured
a 16-fold range for 8 models(3). Rottke et al. used a
different approach, measuring doses for minimum and
maximum exposure parameters provided by 10 CBCT
models, finding a 23-fold dose range(7). It should be
noted that CBCT models often offer a wider range of
exposure parameters than those used for clinical dental
imaging, with lower exposure settings only being used
during quality control and higher exposures being
applied for non-dental (e.g. ear) applications.
Corresponding with the wide range in effective
dose, doses to individual organs show large variations
due to varying exposure settings and FOV positions.
Absorbed organ doses of 0.03–10.0 mGy have been
reported for the thyroid gland, 0.02–9.3 mGy for the
brain and 0.03–16.7 mGy for the eye lens(3 – 6).
Comparing CBCT with those of other modalities,
some overlap is noticeable. CBCT doses of .500 mSv
have been reported(3, 6), whereas low-dose CT proto-
cols of 180 mSv with adequate image quality for
implant and surgery planning have been proposed in
2005 by Loubele et al.(8) Due to the decreased use of
MDCT for dental applications, recent dose reports on
current-generation models are not available; it can be
expected that innovations in detector technology,
image reconstruction and other aspects allow for
MDCT to reach lower doses than those reported in
older literature.
Comparing CBCT with 2D modalities, while there
is a clear difference in dose with intra-oral and ceph-
alometric radiography, some overlap can be seen
between CBCT and panoramic radiography(9).
However, two additional considerations should be
made. While small-FOV CBCTs are able to reach
very low doses, they cannot be considered as true
alternatives for panoramic radiographs, which cover
the entire dentomaxillofacial area. In addition, low-
dose protocols from modern CBCT equipment may
result in doses similar to the high end of the range for
panoramic radiographs reported in literature, but
modern panoramic equipment results in patient doses
that medium- or large-FOV CBCTs cannot possibly
reach.
Most dosimetric studies on CBCT use a similar
methodology, by estimating the effective dose through
point measurements in an anthropomorphic phantom
representing an average adult male. It is important to
remark that dose ranges and dose differences measured
using this approach cover only a small portion of the
actual dose and risk ranges for patients. As noted by
Martin, there can be a large discrepancy between
phantom and patient doses, due to varying patient
anatomy (e.g. mass, size and location of organs)(10).
The use of paediatric phantoms has illustrated that
higher doses are seen for smaller patients when expos-
ure factors are not modified(11, 12). In addition, risks
from radiation exposures are determined not only by
dose but other patient-specific factors such as age and
gender. Therefore, whereas differences in radiation
doses mentioned earlier can often be considered small,
the actual risk can vary severely, particularly for paedi-
atric patients.
SEDENTEXCT GUIDELINES
The SEDENTEXCT (Safety and Efficacy of a New
and Emerging Dental X-ray Modality) project was a
multicentric collaboration, funded by the European
Atomic Energy Community’s Seventh Framework
Programme. Based on an extensive review of literature
and aided by experimental work on radiation dose,
image quality and diagnostic efficacy performed
within the project, evidence-based guidelines were
compiled by the SEDENTEXCT Consortium. These
guidelines are published as Radiation Protection
Publication 172 of the European Commission(1).
Various aspects of radiological protection in dental
CBCT were covered in these guidelines, such as justifi-
cation, optimisation of exposures, user training and
quality assurance. Apart from a detailed description
of guidelines related to these topics with varying evi-
dence levels, twenty ‘Basic Principles’ were defined
using a consensus-based approach, which involved
members of the European Academy of Dento-
Maxillo-Facial Radiology (Table 1).
Several Basic Principles are interpretations of the
general radiological principles of justification and op-
timisation of exposures. Justification is a crucial
aspect, as the excessive use of CBCT in dentistry
would increase the collective dose considerably. The
use of CBCT in dentistry can only be considered as
justified if a patient history and clinical information
are available, if it is expected to add new information
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and if 2D radiographs do not (or are not expected to)
answer the diagnostic question. Repeated CBCT
examination should be avoided unless each examin-
ation can be individually justified. In addition, CBCT
should not be used if soft tissue assessment is
required, since only MDCT or magnetic resonance
imaging provides the contrast resolution required for
soft tissue imaging.
An important optimisation principle in dental
CBCT relates to the choice of the appropriate volume
size for each examination. In many cases, the region
of interest is known exactly before scanning; in other
cases, the required FOV is revealed after acquisition
of a frontal and/or lateral scout image. The smallest
available FOV size should always be chosen, as this
could greatly reduce the patient dose. The choice
between high- and low-dose settings should be made
according to the general principle of optimisation, en-
suring adequate image quality for diagnosis at the
lowest achievable dose. For low-dose protocols, while
conclusive evidence is lacking, recent research has
indicated that an mAs reduction could be preferred
over a kVp reduction, as the increase in noise is
smaller for the former at the same dose level(13).
Since CBCT images often contain structures that
are not part of the diagnostic region of interest (al-
though this should be limited as much as possible
through FOV reduction), the EC guidelines also state
that the entire image should be examined and
reported, not just the region of interest. Depending
on the scanned region, the involvement of an oral or
medical radiologist can be warranted.
(IM)PROPER USE OF CBCT
The (im)proper use of CBCT will be illustrated for
different dental applications. Although it is often
Table 1. ‘Basic Principles’ on the use of dental CBCT(1).
1. CBCTexaminations must not be carried out unless a history and clinical examination have been performed
2. CBCTexaminations must be justified for each patient to demonstrate that the benefits outweigh the risks
3. CBCTexaminations should potentially add new information to aid the patient’s management
4. CBCT should not be repeated ‘routinely’ on a patient without a new risk/benefit assessment having been performed
5. When accepting referrals from other dentists for CBCTexaminations, the referring dentist must supply sufficient clinical
information (results of a history and examination) to allow the CBCT practitioner to perform the justification process
6. CBCT should only be used when the question for which imaging is required cannot be answered adequately by lower
dose conventional (traditional) radiography
7. CBCT images must undergo a thorough clinical evaluation (‘radiological report’) of the entire image data set
8. Where it is likely that evaluation of soft tissues will be required as part of the patient’s radiological assessment, the
appropriate imaging should be conventional medical CTor MR, rather than CBCT
9. CBCTequipment should offer a choice of volume sizes, and examinations must use the smallest that is compatible with
the clinical situation if this provides less radiation dose to the patient
10. Where CBCTequipment offers a choice of resolution, the resolution compatible with adequate diagnosis and the lowest
achievable dose should be used
11. A quality assurance programme must be established and implemented for each CBCT facility, including equipment,
techniques and quality control procedures
12. Aids to accurate positioning (light beam markers) must always be used
13. All new installations of CBCTequipment should undergo a critical examination and detailed acceptance tests before use
to ensure that radiation protection for staff, members of the public and patient are optimal
14. CBCTequipment should undergo regular routine tests to ensure that radiation protection, for both practice/facility
users and patients, has not significantly deteriorated
15. For staff protection from CBCTequipment, the guidelines detailed in Section 6 of the European Commission document
‘Radiation Protection 136. European Guidelines on Radiation Protection in Dental Radiology’ should be followed
16. All those involved with CBCT must have received adequate theoretical and practical training for the purpose of
radiological practices and relevant competence in radiation protection
17. Continuing education and training after qualification are required, particularly when new CBCTequipment or
techniques are adopted
18. Dentists responsible for CBCT facilities who have not previously received ‘adequate theoretical and practical training’
should undergo a period of additional theoretical and practical training that has been validated by an academic
institution (University or equivalent). Where national specialist qualifications in DMFR exist, the design and delivery of
CBCT training programmes should involve a DMF Radiologist
19. For dento-alveolar CBCT images of the teeth, their supporting structures, the mandible and the maxilla up to the floor
of the nose (e.g. 8`  8 cm or smaller fields of view), clinical evaluation (‘radiological report’) should be made by a
specially trained DMF Radiologist or, where this is impracticable, an adequately trained general dental practitioner
20. For non-dento-alveolar small fields of view (e.g. temporal bone) and all craniofacial CBCT images (fields of view
extending beyond the teeth, their supporting structures, the mandible, including the TMJ, and the maxilla up to the floor
of the nose), clinical evaluation (‘radiological report’) should be made by a specially trained DMF Radiologist or by a
Clinical Radiologist (Medical Radiologist)
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debatable whether or not CBCT examinations are ap-
propriate, a few observations can be made.
Implant planning
The most common application of CBCT in dentistry
is for the preoperative planning of implants.
Understandably, it is considered the application for
which the value of 3D imaging is clearest; the
American Academy of Oral and Maxillofacial
Radiology (AAOMR) and European Association of
Osseointegration (EAO) already acknowledged the
benefit of cross-sectional imaging for implant patients
in 2000 and 2002, respectively(1, 14). CBCT allows for
the assessment of bone dimensions and nearby
anatomy at potential implant sites, enabling the prac-
titioner to decide on the proper size and angulation of
implants and to plan the preparation and (if needed)
augmentation of the implant site. Still, an important
remark pertaining to the use of CBCT for implant
patients is that, despite the wide use and availability
of CBCT, there is still a need for more evidence per-
taining to its added value for straightforward implant
cases.
Both the AAOMR and EAO published an updated
position statement on the use of radiography
for implants, with a focus on CBCT, in 2012(14, 15).
The AAOMR recommended that initial assessment
of dental implant patients should be done using
panoramic radiography supplemented by intra-oral
radiography, avoiding the use of CBCT for initial
examination(14). However, they propose that the exam-
ination of a potential implant site should be done
using cross-sectional imaging, with CBCT being the
modality of choice. Conversely, the EAO stated that
no cross-sectional imaging is required if clinical evalu-
ation reveals adequate bone width and 2D radiographs
show bone height and relevant anatomical structures
appropriately(15), whereas the SEDENTEXCT guide-
lines emphasise that ‘the primary question for clini-
cians is whether or not cross-sectional imaging is
required for implant planning’(1). The EAO and
AAOMR are in agreement that particular con-
sideration of CBCT should be made when augmenta-
tion or other preparations of the implant site are
required, both before and after these procedures are
performed.
Regarding post-operative imaging, the application
of CBCT is limited due to the induction of metal
artefacts by implants and an inferior resolution to
intra-oral radiography. The AAOMR and EAO
recommended the use of intra-oral or panoramic
radiography post-operatively, in the absence of signs
or symptoms. Cross-sectional imaging can be consid-
ered if implant mobility, nerve damage or sinus-
related infection is present. For periodic follow-up,
CBCT should not be used unless in cases of implant
failure requiring surgical removal.
It is crucial to remark that these referral criteria
apply only under the strict condition of dose opti-
misation. When acquiring a CBCT image on an
implant patient, it is important to limit the FOV to
the implant site, including any adjacent areas that
require evaluation (e.g. maxillary sinus). In addition,
the required image quality for this application is rela-
tively limited (e.g. bone dimensional assessment,
general evaluation of bone quality and visualisation
of adjacent structures), implying that low-dose proto-
cols would generally suffice.
Endodontic evaluation
The European Society of Endodontology (ESE) has
recently published a brief position statement on the use
of CBCT in endodontics(16), whereas the American
Association of Endodontists (AAE) in collaboration
with the AAOMR published a position paper in
2011(17). Both publications show considerable agree-
ment with the SEDENTEXCT guidelines(1). Their
main recommendation is the consistent use of small
FOVs for endodontic purposes, as these are typically
confined to a single tooth and its adjacent area.
Another benefit of small FOVs is that they can be
reconstructed at smaller voxel sizes than large FOVs
due to computational and storage limitations of the
current technology; the increased spatial resolution
which is, up to a certain limit, associated with smaller
voxels can be of benefit for several endodontic
applications.
The ESE recommended that CBCT may be consid-
ered for the following endodontic applications,
should 2D radiography not suffice: periapical patho-
sis with contradictory signs/symptoms, non-odonto-
genic causes of pathosis, complex dento-alveolar
trauma (e.g. horizontal root fractures), complex root
canal systems prior to endodontic treatment, compli-
cations of endodontic treatments (e.g. perforations),
root resorption amenable to treatment and pretreat-
ment assessment of complex periradicular surgery(16).
Similarly, the AAE-AAOMR have stated that limited-
FOV, high-resolution CBCT can be applied to
complex endodontic cases(17). The use of intra-opera-
tive and post-operative CBCT for endodontic purposes
is inappropriate. The former is not only inconvenient
for both patient and dentist but has little or no benefit
compared with intra-oral radiography, except for
certain intra-operative complications. The latter may
only be advised if symptoms remain or complications
arise.
Orthodontics
The use of CBCT in orthodontics is of particular
concern due to the younger age (and associated
higher cancer risk) of patients undergoing orthodon-
tic treatment. In addition, patient gender is of
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importance, due to the higher radiation risk for
females at younger ages and the earlier development
of dentition in females. A position statement by the
AAOMR provided general recommendations on jus-
tification and optimisation of CBCT before, during
and after treatment for various types of orthodontic
patients(18).
Selection criteria from the AAOMR indicate that
CBCT is likely indicated during (1) pretreatment
evaluation of dental structure/position anomalies
(e.g. supernumerary teeth, resorption and impaction),
using a small FOV and (2) presurgical asymmetry
evaluation (e.g. mandibular or midline deviation),
using a medium or large FOV. The SEDENTEXCT
guidelines agree on the potential of CBCT for loca-
lised applications but reject the routine use of large-
FOV CBCT for orthodontic purposes, highlighting
the need for more research demonstrating its benefit
to patient outcome(1). For other applications, such as
imaging of the temporomandibular joint (e.g. hyper/
hypoplasia) and facial discrepancies (e.g. malocclu-
sions, crossbites), CBCT may or may not be indicated
on a case-by-case basis and should be considered as
an alternative for cases that used to require MDCT
examination, provided that the dose is lower and soft
tissue imaging is not required. For the majority of
orthodontic applications, post-treatment CBCTs are
not likely indicated.
Apart from using the smallest possible FOV, one
must reduce exposure parameters compared with
those applied for an adult patient, taking the increase
in dose and risk for children into account.
General misuses of CBCT
Cases in which the use of CBCT is inappropriate
can be derived from Table 1, but will be briefly sum-
marised. In general, routine use of CBCT without
judicious evaluation of patient history, a clinical
examination and previously acquired radiographs
should not be done. Diagnoses or treatments that
can be adequately performed through the use of
2D radiography or non-ionising modalities do not
require CBCT. When a particular CBCT scanner
does not allow for the adjustment of exposure para-
meters (e.g. FOV, mAs) suited for a particular
patient, it should not be used; when possible, alter-
native CBCT models should be used instead. This
implies that CBCT users, when purchasing a CBCT
scanner, should be aware of the expected applica-
tion range and choose a model with a fitting ex-
posure range. Referring practitioners, when having
a choice between several CBCT scanners, should be
aware of the parameter ranges provided by each
model and choose the most appropriate scanner
for each patient rather than routinely opting for
one scanner for reasons other than radiological
protection.
FUTURE PROSPECTS
This paper provided a brief overview of radiation dose
issues associated with the use of CBCT in dentistry.
Through the use of different guidelines and position
papers, the (mis)use of CBCT was illustrated for
several dental applications.
As mentioned in each of the above-mentioned
guidelines and position statements, periodic review is
required in order to apply the most recent information
on diagnostic efficacy and radiation dose and risk. In
particular, as more comparative studies focusing on
patient outcome become available, recommendations
regarding the use of CBCT as a supplement or com-
plement to 2D radiography may alter considerably. On
the other hand, technological developments allowing
for the reduction of patient dose (e.g. automatic expos-
ure control, advanced reconstruction algorithms and
improved detector technology) may increase overall
confidence in the net benefit of CBCT. The use of
health economics is warranted to evaluate all factors
associated with the use of CBCT vs. alternative imaging
modalities.
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